Pre-Open Stock Movers 01/27: (GLPG) (NOW) (XM) Higher; (EPZM) (LC) (ZYME) Lower (more...)

January 27, 2022 9:17 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Pre-Open Stock Movers:

Epizyme, Inc. (Nasdaq: EPZM) 31% LOWER; announced the pricing of an underwritten public offering of 56,666,667 shares of its common stock at a price to the public of $1.50 per share, before underwriting discounts.

LendingClub (NYSE: LC) 20% LOWER; reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $262.2 million versus the consensus estimate of $245.8 million. LendingClub sees Q1 2022 revenue of $255-265 million, versus the consensus of $257 million. LendingClub sees FY2022 revenue of $1.1-1.2 billion, versus the consensus of $1.16 billion.

Galapagos NV (NASDAQ: GLPG) 15% HIGHER; announce the appointment of Dr. Paul Stoffels as Chief Executive Officer (CEO), effective April 1, 2022. Dr. Stoffels brings an impressive track record of success in innovative drug discovery and development, and a wealth of experience in biotech and pharma, across a range of roles and therapeutic areas.

Zymeworks Inc. (NYSE: ZYME) 11% LOWER; announced the pricing of its underwritten public offering of 9,160,000 common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 3,340,000 common shares

ServiceNow (NYSE: NOW) 10.5% HIGHER; reported Q4 EPS of $1.46, $0.03 better than the analyst estimate of $1.43. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.6 billion. Sees Q1 Subscription revenues of $1.61-$1.615 billion. Sees FY22 Subscription revenues of $7.02-$7.04 billion.

Qualtrics International (NASDAQ: XM) 9.3% HIGHER; reported Q4 EPS of ($0.07), $0.05 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $316 million versus the consensus estimate of $297.61 million.

Xilinx (NASDAQ: XLNX) 7.4% HIGHER; China has approved AMD's (NASDAQ: AMD) purchase of Xilinx (NASDAQ: XLNX) with conditions.

Flex Ltd. (NASDAQ: FLEX) 6% HIGHER; reported Q3 EPS of $0.50, $0.13 better than the analyst estimate of $0.37. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $5.6 billion. Flex Ltd. sees Q4 2022 EPS of $0.41-$0.46, versus the consensus of $0.39. Flex Ltd. sees Q4 2022 revenue of $6.2-6.6 billion, versus the consensus of $5.68 billion. Flex Ltd. sees FY2022 EPS of $1.85-$1.90, versus the consensus of $1.58. Flex Ltd. sees FY2022 revenue of $25.4-25.8 billion, versus the consensus of $22.34 billion.

GitLab Inc (NASDAQ: GTLB) 6% HIGHER; JPMorgan upgraded from Neutral to Overweight with a price target of $99.00.

Levi (NYSE: LEVI) 5.8% HIGHER; reported Q4 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.68 billion. Levi sees FY2022 EPS of $1.50-$1.56, versus the consensus of $1.53. Levi sees FY2022 revenue of $6.4-6.5 billion, versus the consensus of $6.38 billion.

Lam Research (NASDAQ: LRCX) 5.8% LOWER; reported Q4 EPS of $8.53, $0.02 better than the analyst estimate of $8.51. Revenue for the quarter came in at $4.23 billion versus the consensus estimate of $4.41 billion. Lam Research sees Q1 2023 EPS of $7.45 at the midpoint, versus the consensus of $8.72. Lam Research sees Q1 2023 revenue of $4.25 billion at the midpoint, versus the consensus of $4.49 billion.

Edwards Lifesciences (NYSE: EW) 5% LOWER; reported Q4 EPS of $0.51, $0.04 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.36 billion. Edwards Lifesciences sees Q1 2022 EPS of $0.54-$0.62, versus the consensus of $0.60. Edwards Lifesciences sees Q1 2022 revenue of $1.27-1.35 billion, versus the consensus of $1.36 billion. Edwards Lifesciences sees FY2022 EPS of $2.50-$2.65, versus the consensus of $2.58. Edwards Lifesciences sees FY2022 revenue of $5.5-6 billion, versus the consensus of $5.82 billion.

Centene (NYSE: CNC) 5% HIGHER; fielded takeover interest from Cigna Corp. (NYSE: CI) in recent months, according to Bloomberg, citing people familiar with the matter.

Netflix (NASDAQ: NFLX) 4.5% HIGHER; Bill Ackman said his Pershing Square hedge fund bought over 3.1 million shares of Netflix following the recent slide in the stock. This makes the firm a top-20 holder.

Intel (NASDAQ: INTC) 3.4% LOWER; reported Q4 EPS of $1.09, $0.19 better than the analyst estimate of $0.90. Revenue for the quarter came in at $20.5 billion versus the consensus estimate of $18.32 billion. Intel sees Q1 2022 EPS of $0.80, versus the consensus of $0.86. Intel sees Q1 2022 revenue of $18.3 billion, versus the consensus of $17.62 billion.

McDonald's (NYSE: MCD) 2.5% LOWER; reported Q4 EPS of $2.23, $0.11 worse than the analyst estimate of $2.34. Revenue for the quarter came in at $6.01 billion versus the consensus estimate of $6.03 billion. Global comparable sales increased 12.3% (10.8% on a 2-year basis), reflecting positive comparable sales across all segments.

Unity Software Inc. (NYSE: U) 2.1% HIGHER; added to the Wedbush Best Ideas List.

Tesla (NASDAQ: TSLA) 1.2% HIGHER; reported Q4 EPS of $2.54, $0.28 better than the analyst estimate of $2.26. Revenue for the quarter came in at $17.72 billion versus the consensus estimate of $16.35 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

William Ackman, Pershing Square Capital, JPMorgan, Tesla, Wedbush Best Ideas List, Pre-Open Losers, Pre-Open Winners, Pre Market Movers